Vaccinex, Inc.
VCNX
$0.72
-$0.02-2.70%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 309.62% | -77.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 309.62% | -77.59% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -23,815.38% | 101.43% | |||
| SG&A Expenses | 1.95% | -31.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.81% | -22.67% | |||
| Operating Income | 25.59% | 20.45% | |||
| Income Before Tax | 41.14% | -1.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 41.14% | -1.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 41.14% | -1.79% | |||
| EBIT | 25.59% | 20.45% | |||
| EBITDA | 25.57% | 20.51% | |||
| EPS Basic | 62.99% | 8.72% | |||
| Normalized Basic EPS | 62.99% | 8.72% | |||
| EPS Diluted | 62.99% | 8.72% | |||
| Normalized Diluted EPS | 62.99% | 8.72% | |||
| Average Basic Shares Outstanding | 59.04% | 11.52% | |||
| Average Diluted Shares Outstanding | 59.04% | 11.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||